XNCR


Xencor Inks Collaboration and License Agreement with Janssen; Shares Rise

Xencor, Inc. (XNCR) and Janssen Biotech, a Johnson & Johnson (JNJ) company, have entered into a global collaboration and license agreement to develop …

Xencor Presents Positive Data For XmAb Antibodies Program Against Cancer

Xencor presented new data from multiple preclinical studies for XmAb bispecific antibody and its preclinical IL-12-Fc cytokine program at the American Association for …

DEALS AND RUMORS OF DEALS DOMINATED THIS WEEK IN HEALTHCARE

This week was a busy one for biopharma BD teams. Finallized on Sunday, Valeant (VRX) will pay $158 per share for Salix Pharmaceuticals (SLXP) in an all-cash …

Investors Should be Paying Attention to Xencor

Xencor, Inc (NASDAQ:XNCR) priced an equity financing on Wednesday morning, selling 7.5 million shares of common stock at $14.

MLV Initiates Buy On Xencor, Sees 46% Upside For The Stock

In a research report released today, MLV analyst Arlinda Lee initiated coverage on shares of Xencor (NASDAQ:XNCR) with a Buy rating and a …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts